+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Blood Disease"

Hematology Analyzer Market - Product Thumbnail Image

Hematology Analyzer Market

  • Report
  • June 2023
  • 144 Pages
  • Global
From
From
From
From
From
Global Non-Cancerous Blood Disease Market Analysis 2021-2031 - Product Thumbnail Image

Global Non-Cancerous Blood Disease Market Analysis 2021-2031

  • Report
  • April 2022
  • 307 Pages
  • Global
From
From
Molecular Hematology. Edition No. 5 - Product Thumbnail Image

Molecular Hematology. Edition No. 5

  • Book
  • April 2024
  • 448 Pages
Molecular Hematology. Edition No. 4 - Product Thumbnail Image

Molecular Hematology. Edition No. 4

  • Book
  • November 2019
  • 432 Pages
Molecular Hematology. Edition No. 4 - Product Thumbnail Image

Molecular Hematology. Edition No. 4

  • Book
  • November 2019
  • 432 Pages
Loading Indicator

The Blood Disease market within the context of Hematology is a broad and diverse field of study. It encompasses a wide range of conditions, from common blood disorders such as anemia and hemophilia to rarer conditions such as thalassemia and sickle cell anemia. Hematology also covers the diagnosis and treatment of blood cancers, including leukemia, lymphoma, and multiple myeloma. In addition, hematology includes the study of blood clotting and transfusion medicine. The Blood Disease market is a rapidly growing field, with new treatments and therapies being developed to improve patient outcomes. Companies in this market are focused on developing innovative treatments and therapies for blood diseases, as well as diagnostic tools and technologies to improve diagnosis and treatment. Examples of companies in this market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more